Funds And Strategies
  • Business
  • Stocks
  • World News
  • Investing
  • Business
  • Stocks
  • World News
  • Investing

Funds And Strategies

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin June 4, 2025
June 4, 2025
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

previous post
5 Biggest Blockchain ETFs in 2025
next post
Bird Flu Vaccine Stocks: 8 Companies Developing H5N1 Vaccines

Related Posts

China’s Breakthrough in Uranium Seawater Extraction Boosts Efficiency...

June 4, 2025

Silver Crown Royalties Announces Non-Brokered Private Placement

May 20, 2025

How to Invest in Silver: Buying Bullion, Stocks...

May 28, 2025

Quimbaya Gold Announces Strategic Private Placement of up...

May 29, 2025

Joe Cavatoni: Gold’s Record Run No Surprise, Here’s...

May 7, 2025

Exceptional Lithium Intercept Extends Red Mountain Discovery Further...

May 19, 2025

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (89)
    • Investing (318)
    • Stocks (107)
    • World News (391)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 fundsandstrategies.com | All Rights Reserved